Zenas BioPharma's obexelimab for IgG4-related disease (IgG4-RD) has been accepted by the FDA with a PDUFA date set for May 27, 2027. The drug offers a unique non-depleting B cell inhibition, potentially safer for long-term use in older patients compared to existing treatments like Uplizna. The company has sufficient cash to operate into late 2028 but faces financing risks if FDA approval is delayed. Upcoming data from other trials and regulatory filings will be important for the company's valuation and future prospects.
Zenas BioPharma's obexelimab development is the subject here. For readers following the health sector, of 100 priced US health stocks on Pluang, 37 rose and 58 fell today. AMLX was at USD 27.67 with a 1-day change of -4.91%, TMDX at USD 79.79 with -4.39%, and ABEO at USD 5.03 with -4.19%, as of Oct 05, 2026 14:11 WIB.
In 2026, Solana's price shows a 2.4% gain in euros but a 2.5% loss in dollars, driven by the euro weakening 4.47% against the dollar. This currency effect impacts German investors' tax calculations, as gains and losses must be reported in euros using...
The Sandbox (SAND) cryptocurrency surged about 63.64% last week, continuing to rise to 68.82% weekly gains after major exchanges Upbit, Bithumb, and Coinone removed a trading caution placed in August. The caution was initially due to a security breac...
Luxxfolio Holdings Inc. announced a proposed collaboration with Hypercall to generate option premium income by selling covered calls on its Litecoin and Dogecoin holdings. This initiative aims to create a secondary revenue stream to support Luxxfolio...
CAE, a leader in flight training and simulation, maintains a Buy rating with a $29.85 price target, implying 24% upside. The company is undergoing a multi-year transformation targeting $125–$150 million in annual savings by 2030, with benefits expect...
Goldman Sachs' Anthony Gutman highlighted the challenge of rising government bond yields in Western economies, citing recent instability in U.S. Treasurys and French bonds. He emphasized the need for governments to reduce fiscal deficits and promote ...
